Sarepta’s Elevidys Limited To Ambulatory DMD Patients; Study In Non-Ambulatory Patients Planned

 
• By Mandy Jackson
  
Elevidys is contraindicated in patients with DMD exon 8 and/or 9 deletions (Shutterstock)

More from Cell & Gene Therapies

More from Advanced Technologies